The U.S. Federal Trade Commission (FTC) has sued telehealth company Hims & Hers for allegedly sharing users' sensitive health data with advertisers like Meta and Snap, despite promising privacy. The FTC also accused the company of deceptive billing, charging users for prescriptions before consultations, and making subscription cancellations difficult. Hims & Hers denied the claims, calling the lawsuit a publicity stunt. The lawsuit could impact the company's reputation and stock, which fell about 12% after the news.
Hims & Hers Health is being sued by the Federal Trade Commission for alleged consumer protection violations, which coincided with a major market downturn. Despite the lawsuit, the company denies wrongdoing and the panic seems unwarranted given simila...
The Federal Trade Commission (FTC) is suing healthcare company Hims & Hers for allegedly sharing customers' sensitive medical data with advertisers and tech giants like Meta and Snap without consent. The FTC claims Hims & Hers used pixel trackers to ...
Wall Street experienced a significant selloff with the Nasdaq 100 nearing correction territory and the Dow Jones dropping over 1,000 points, wiping out recent gains. The selloff is driven by fears of rising interest rates after three Federal Reserve ...
The Federal Trade Commission (FTC) has filed a lawsuit against Hims & Hers Health, Inc., alleging the company misled consumers by charging for prescriptions immediately after intake forms were submitted, despite promising consultations to find suitab...
The Federal Trade Commission sued telehealth company Hims & Hers, accusing it of improperly sharing sensitive user health data with advertisers like Meta and Snap without consent. The FTC also alleges the company charged customers for prescriptions b...
